Alignment Healthcare, Inc.
ALHCNASDAQHealthcare● Active
$15.35
$-0.02(-0.13%)
Market Cap$3.2B
P/E Ratio—
52W High$23.87
52W Low$11.625
Alignment Healthcare, Inc. (ALHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALHC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.05
Est. $0.01 · +400.0%
Revenue
$1.24B
Est. $1.22B · +1.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 8-Quarter EPS Beat Streak
ALHC reports quarterly as a NASDAQ-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $0.13 | — | — | — | $1.31B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $0.01 | $0.05 | +400.0% | $1.24B | $1.22B | +1.4% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.15 | -$0.05 | +66.7% | $1.01B | $1.00B | +0.9% |
| ▲ Q4 FY2025 | Oct 30, 2025 | -$0.01 | $0.02 | +300.0% | $0.99B | $0.98B | +1.3% |
| ▲ Q3 FY2025 | Jul 30, 2025 | -$0.07 | $0.07 | +200.0% | $1.02B | $0.96B | +5.8% |
| ▲ Q2 FY2025 | May 1, 2025 | -$0.12 | -$0.05 | +58.3% | $0.93B | $0.89B | +4.3% |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.18 | -$0.16 | +11.1% | $0.70B | $0.68B | +3.5% |
| — Q4 FY2024 | Oct 29, 2024 | -$0.14 | -$0.14 | +0.0% | $0.69B | $0.68B | +2.5% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$0.13
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$0.05
EPS Est.
$0.01
EPS Surpr.
+400.0%
Revenue
$1.24B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$0.05
EPS Est.
-$0.15
EPS Surpr.
+66.7%
Revenue
$1.01B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$0.02
EPS Est.
-$0.01
EPS Surpr.
+300.0%
Revenue
$0.99B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$0.07
EPS Est.
-$0.07
EPS Surpr.
+200.0%
Revenue
$1.02B
Q2 FY2025
May 1, 2025Beat
EPS Actual
-$0.05
EPS Est.
-$0.12
EPS Surpr.
+58.3%
Revenue
$0.93B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.18
EPS Surpr.
+11.1%
Revenue
$0.70B
Q4 FY2024
Oct 29, 2024
EPS Actual
-$0.14
EPS Est.
-$0.14
EPS Surpr.
+0.0%
Revenue
$0.69B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.09 | $0.09 | $0.09 | 1 |
| Q3 FY2028 | $0.22 | $0.22 | $0.23 | 1 |
| Q2 FY2028 | $0.33 | $0.33 | $0.33 | 1 |
| Q1 FY2028 | $0.19 | $0.19 | $0.19 | 1 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 1 |
| Q3 FY2027 | $0.12 | $0.12 | $0.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $2.1B | $2.1B | $2.2B | 6 |
| Q3 FY2028 | $2.1B | $2.1B | $2.1B | 3 |
| Q2 FY2028 | $2.1B | $2.1B | $2.1B | 5 |
| Q1 FY2028 | $2.0B | $2.0B | $2.0B | 3 |
| Q4 FY2027 | $1.7B | $1.7B | $1.7B | 7 |
| Q3 FY2027 | $1.6B | $1.7B | $1.7B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +400.0% | $21.72 | $22.54 | +3.78% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +66.7% | $20.13 | $20.42 | +1.44% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +300.0% | $18.21 | $17.12 | -5.99% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +200.0% | $11.78 | $13.00 | +10.36% |
| ▲ Q2 FY2025 | May 1, 2025 | +58.3% | $17.72 | $16.77 | -5.36% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +11.1% | $13.16 | $13.47 | +2.36% |
| ▲ Q4 FY2024 | Oct 29, 2024 | +0.0% | $11.54 | $11.71 | +1.47% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +7.1% | $8.74 | $8.62 | -1.37% |
Q2 FY2026+3.78%
Report Date
Apr 30, 2026
EPS Beat/Miss
+400.0%
Price Before
$21.72
Price After
$22.54
Q1 FY2026+1.44%
Report Date
Feb 26, 2026
EPS Beat/Miss
+66.7%
Price Before
$20.13
Price After
$20.42
Q4 FY2025-5.99%
Report Date
Oct 30, 2025
EPS Beat/Miss
+300.0%
Price Before
$18.21
Price After
$17.12
Q3 FY2025+10.36%
Report Date
Jul 30, 2025
EPS Beat/Miss
+200.0%
Price Before
$11.78
Price After
$13.00
Q2 FY2025-5.36%
Report Date
May 1, 2025
EPS Beat/Miss
+58.3%
Price Before
$17.72
Price After
$16.77
Q1 FY2025+2.36%
Report Date
Feb 27, 2025
EPS Beat/Miss
+11.1%
Price Before
$13.16
Price After
$13.47
Q4 FY2024+1.47%
Report Date
Oct 29, 2024
EPS Beat/Miss
+0.0%
Price Before
$11.54
Price After
$11.71
Q3 FY2024-1.37%
Report Date
Aug 1, 2024
EPS Beat/Miss
+7.1%
Price Before
$8.74
Price After
$8.62
Avg Beat Reaction+0.84%
Beat Rate8 / 8 quarters
Largest Move+10.36% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALHC ends December
Alignment Healthcare, Inc. (ALHC) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.05 — beating the analyst consensus of $0.01 by +400.0%. ALHC has beaten EPS estimates for 8 consecutive quarters. The next ALHC earnings date is expected around September 1, 2026.
Each quarter, investors track ALHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALHC earnings · 5 questionsAlignment Healthcare, Inc.'s next earnings report is expected around September 1, 2026. ALHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALHC historically reports after market close (AMC).
ALHC earnings datewhen is ALHC earningsALHC next earnings datewhen does ALHC report earningsALHC earnings calendar
▸ Source: FMP · Alignment Healthcare, Inc. SEC filings · US GAAP · Alignment Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026